|
1
|
Barkund S, Shah T, Ambatkar N, Gadgil M
and Joshi K: FOXO3a gene polymorphism associated with asthma in
Indian population. Mol Biol Int. 2015(638515)2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bacharier LB and Geha RS: Molecular
mechanisms of IgE regulation. J Allergy Clin Immunol.
105:S547–S558. 2000.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Afshari JT, Hosseini RF, Farahabadi SH,
Heydarian F, Boskabady MH, Khoshnavaz R, Razavi A, Karimiani EG and
Ghasemi G: Association of the expression of IL-4 and IL-13 genes,
IL-4 and IgE serum levels with allergic asthma. Iran J Allergy
Asthma Immunol. 6:67–72. 2007.PubMed/NCBI
|
|
4
|
Humbert M, Corrigan CJ, Kimmitt P, Till
SJ, Kay AB and Durham SR: Relationship between IL-4 and IL-5 mRNA
expression and disease severity in atopic asthma. Am J Respir Crit
Care Med. 156:704–708. 1997.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Buitkamp J, Jann O and Fries R: The cattle
interleukin-13 gene: Genomic organization, chromosomal location,
and evolution of the promoter. Immunogenetics. 49:872–878.
1999.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Dolecek C, Steinberger P, Susani M, Kraft
D, Valenta R and Boltz-Nitulescu G: Effects of IL-4 and IL-13 on
total and allergen specific IgE production by cultured PBMC from
allergic patients determined with recombinant pollen allergens.
Clin Exp Allergy. 25:879–889. 1995.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ådjers K, Pessi T, Karjalainen J, Huhtala
H and Hurme M: Epistatic effect of IL1A and IL4RA genes on the risk
of atopy. J Allergy Clin Immunol. 113:445–447. 2004.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hunninghake GM, Soto-Quirós ME, Avila L,
Su J, Murphy A, Demeo DL, Ly NP, Liang C, Sylvia JS, Klanderman BJ,
et al: Polymorphisms in IL13, total IgE, eosinophilia, and asthma
exacerbations in childhood. J Allergy Clin Immunol. 120:84–90.
2007.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Park SW, Jangm HK, An MH, Min JW, Jang AS,
Lee JH and Park CS: Interleukin-13 and interleukin-5 in induced
sputum of eosinophilic bronchitis: Comparison with asthma. Chest.
128:1921–1927. 2005.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wynn TA: IL-13 effector functions. Annu
Rev Immunol. 21:425–456. 2003.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Shirakawa I, Deichmann KA, Izuhara I, Mao
I, Adra CN and Hopkin JM: Atopy and asthma: Genetic variants of
IL-4 and IL-13 signalling. Immunol Today. 21:60–64. 2000.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Bancroft AJ, McKenzie AN and Grencis RK: A
critical role for IL-13 in resistance to intestinal nematode
infection. J Immunol. 160:3453–3461. 1998.PubMed/NCBI
|
|
13
|
Ober C and Cox NJ: The genetics of asthma.
Mapping genes for complex traits in founder populations. Clin Exp
Allergy. 28 (Suppl 1):101–110. 1998.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Meyers DA, Postma DS, Panhuysen CI, Xu J,
Amelung PJ, Levitt RC and Bleecker ER: Evidence for a locus
regulating total serum IgE levels mapping to chromosome 5.
Genomics. 23:464–470. 1994.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Bleecker ER, Amelung PJ, Levitt RC, Postma
DS and Meyers DA: Evidence for linkage of total serum IgE and
bronchial hyperresponsiveness to chromosome 5q: A major regulatory
locus important in asthma. Clin Exp Allergy. 25 (Suppl 2):84–88;
discussion 95-96. 1995.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Cameron L, Webster RB, Strempel JM,
Kiesler P, Kabesch M, Ramachandran H, Yu L, Stern DA, Graves PE,
Lohman IC, et al: Th2 cell-selective enhancement of human IL13
transcription by IL13-1112C>T, a polymorphism associated with
allergic inflammation. J Immunol. 177:8633–8642. 2006.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Vladich FD, Brazille SM, Stern D, Peck ML,
Ghittoni R and Vercelli D: IL-13 R130Q, a common variant associated
with allergy and asthma, enhances effector mechanisms essential for
human allergic inflammation. J Clin Invest. 115:747–754.
2005.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Howard TD, Whittaker PA, Zaiman AL,
Koppelman GH, Xu J, Hanley MT, Meyers DA, Postma DS and Bleecker
ER: Identification and association of polymorphisms in the
interleukin-13 gene with asthma and atopy in a Dutch population. Am
J Respir Cell Mol Biol. 25:377–384. 2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kabesch M, Schedel M, Carr D, Woitsch B,
Fritzsch C, Weiland SK and von Mutius E: IL-4/IL-13 pathway
genetics strongly influence serum IgE levels and childhood asthma.
J Allergy Clin Immunol. 117:269–274. 2006.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Peng SL: Forkhead transcription factors in
chronic inflammation. Int J Biochem Cell Biol. 42:482–485.
2010.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Tikhanovich I, Cox J and Weinman SA:
Forkhead box class O transcription factors in liver function and
disease. J Gastroenterol Hepatol. 28 (Suppl 1):125–131.
2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hwang JW, Rajendrasozhan S, Yao H, Chung
S, Sundar IK, Huyck HL, Pryhuber GS, Kinnula VL and Rahman I: FOXO3
deficiency leads to increased susceptibility to cigarette
smoke-induced inflammation, airspace enlargement, and chronic
obstructive pulmonary disease. J Immunol. 187:987–998.
2011.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lunghi B, De Cunto G, Cavarra E, Fineschi
S, Bartalesi B, Lungarella G and Lucattelli M: Smoking p66Shc
knocked out mice develop respiratory bronchiolitis with fibrosis
but not emphysema. PLoS One. 10(e0119797)2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Im J, Hergert P and Nho RS: Reduced FoxO3a
expression causes low autophagy in idiopathic pulmonary fibrosis
fibroblasts on collagen matrices. Am J Physiol Lung Cell Mol
Physiol. 309:L552–L561. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Lee JC, Espéli M, Anderson CA, Linterman
MA, Pocock JM, Williams NJ, Roberts R, Viatte S, Fu B, Peshu N, et
al: UK IBD Genetics Consortium: Human SNP links differential
outcomes in inflammatory and infectious disease to a
FOXO3-regulated pathway. Cell. 155:57–69. 2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Xia M and Zhu Y: FOXO3a involvement in the
release of TNF-α stimulated by ATP in spinal cord astrocytes. J Mol
Neurosci. 51:792–804. 2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Amarin JZ, Naffa RG, Suradi HH, Alsaket
YM, Obeidat NM, Mahafza TM and Zihlif MA: An intronic
single-nucleotide polymorphism (rs13217795) in FOXO3 is associated
with asthma and allergic rhinitis: A case-case-control study. BMC
Med Genet. 18(132)2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
The World Medical Association (WMA). The
WMA declaration of Helsinki 1960 with recommendations on biomedical
research on human subjects (modified in. 1975, 1980 and 1989).
Chirurgia (Bucur). 93:138–140. 1998.PubMed/NCBI(In Romanian).
|
|
29
|
Alvarez-Rodríguez L, López-Hoyos M,
Carrasco-Marín E, Mata C, Calvo-Alén J, Aurrecoechea E, Blanco R,
Ruiz T, Muñoz Cacho P, Villa I, et al: Analysis of the rs20541
(R130Q) polymorphism in the IL-13 gene in patients with
elderly-associated chronic inflammatory diseases. Reumatol Clin.
8:321–327. 2012.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Hasnain A: Polymorphisms of interleukin 13
(IL13) in Local Asthmatic Population. University Of Health Sciences
Lahore, 2008.
|
|
31
|
Health NIo: Global strategy for asthma
management and prevention. In: Global Initiative for Asthma.
National Institute of Health, National Heart Lung and Blood
Institute, Bethesda, 1995.
|
|
32
|
Rengganis I, Rambe DS, Rumende CM and
Abdullah M: Total serum IgE levels among adults patients with
intermittent and persistent allergic asthmas. Med J Indones.
27:279–283. 2018.
|
|
33
|
Bullone M, Carriero V, Bertolini F, Folino
A, Mannelli A, Di Stefano A, Gnemmi I, Torchio R and Ricciardolo
FL: Elevated serum IgE, oral corticosteroid dependence and IL-17/22
expression in highly neutrophilic asthma. Eur Respir J.
54(1900068)2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Siroux V, González JR, Bouzigon E,
Curjuric I, Boudier A, Imboden M, Anto JM, Gut I, Jarvis D, Lathrop
M, et al: Genetic heterogeneity of asthma phenotypes identified by
a clustering approach. Eur Respir J. 43:439–452. 2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Heinzmann A, Mao XQ, Akaiwa M, Kreomer RT,
Gao PS, Ohshima K, Umeshita R, Abe Y, Braun S, Yamashita T, et al:
Genetic variants of IL-13 signalling and human asthma and atopy.
Hum Mol Genet. 9:549–559. 2000.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Holgate ST: Innate and adaptive immune
responses in asthma. Nat Med. 18:673–683. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
37
|
Liao N, Zhao H, Chen ML and Xie ZF:
Association of the IL-13 polymorphisms rs1800925 and rs20541 with
chronic obstructive pulmonary disease risk: An updated
meta-analysis. Medicine (Baltimore). 96(e8556)2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Fahy JV: Type 2 inflammation in
asthma--present in most, absent in many. Nat Rev Immunol. 15:57–65.
2015.PubMed/NCBI View
Article : Google Scholar
|
|
39
|
Maier LM, Howson JM, Walker N, Spickett
GP, Jones RW, Ring SM, McArdle WL, Lowe CE, Bailey R and Payne F:
Association of IL13 with total IgE: Evidence against an inverse
association of atopy and diabetes. J Allergy Clin Immunol.
117:1306–1313. 2006.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Cui L, Jia J, Ma C-F, Li S-Y, Wang Y-P,
Guo X-M, Li Q, Yu HB, Liu WH and Gao LB: IL-13 polymorphisms
contribute to the risk of asthma: A meta-analysis. Clin Biochem.
45:285–288. 2012.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Smolkova B, Tulinska J, Palkovicova
Murinova L, Buocikova V, Liskova A, Rausova K, Kuricova M, Patayova
H, Sustrova M, Neubauerova Svorcova E, et al: Impact of interleukin
13 (IL13) genetic polymorphism Arg130Gln on total serum
immunoglobulin (IgE) levels and interferon (IFN)-γ gene expression.
Clin Exp Immunol. 188:45–52. 2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Halwani R, Vazquez-Tello A, Kenana R,
Al-Otaibi M, Alhasan KA, Shakoor Z and Al-Muhsen S: Association of
IL-13 rs20541 and rs1295686 variants with symptomatic asthma in a
Saudi Arabian population. J Asthma. 55:1157–1165. 2018.PubMed/NCBI View Article : Google Scholar
|
|
43
|
El-Sayed ZA, El-Sayed SS and Eladawy SG:
IL-13 R130Q single nucleotide polymorphism in asthmatic Egyptian
children. Egypt J Pediatr Allergy Immunol. 8:2010.
|
|
44
|
Xu Y, Li J, Ding Z, Li J, Li B, Yu Z and
Tan W: Association between IL-13 +1923C/T polymorphism and asthma
risk: A meta-analysis based on 26 case-control studies. Biosci Rep:
Jan 27, 2017 (Epub ahead of print). doi: 10.1042/BSR20160505.
|
|
45
|
Wynn TA: Type 2 cytokines: Mechanisms and
therapeutic strategies. Nat Rev Immunol. 15:271–282.
2015.PubMed/NCBI View
Article : Google Scholar
|
|
46
|
Brightling CE, Nordenmark LH, Jain M,
Piper E, She D, Braddock M, Colice G and Tornling G: Effect of
anti-IL-13 treatment on airway dimensions in severe asthma. Am J
Respir Crit Care Med. 194:118–120. 2016.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Martin K, Ohayon D and Witko-Sarsat V:
Promoting apoptosis of neutrophils and phagocytosis by macrophages:
Novel strategies in the resolution of inflammation. Swiss Med Wkly.
145(w14056)2015.PubMed/NCBI View Article : Google Scholar
|
